Medical News

RSS
Neurodyn acquires all assets related to new drug candidate Memogain from Galantos Pharma

Neurodyn acquires all assets related to new drug candidate Memogain from Galantos Pharma

Affinium initiates dosing in Phase 1 IV clinical trial of antibiotic prodrug, AFN-1720

Affinium initiates dosing in Phase 1 IV clinical trial of antibiotic prodrug, AFN-1720

Sanofi, POZEN ink license agreement to commercialize PA8140 and PA32540 tablets in US

Sanofi, POZEN ink license agreement to commercialize PA8140 and PA32540 tablets in US

Dementia risk for bipolar disorder patients

Dementia risk for bipolar disorder patients

Menopause findings show asthma to be ‘women’s health issue’

Menopause findings show asthma to be ‘women’s health issue’

Increased mortality in schizophrenia ‘not attributable to drug therapy’

Increased mortality in schizophrenia ‘not attributable to drug therapy’

HeartIT receives $2.5M NIH grant to develop Cloud Based Corelab of the Future

HeartIT receives $2.5M NIH grant to develop Cloud Based Corelab of the Future

Health Project announces Dell as winner of 2013 C. Everett Koop National Health Award

Health Project announces Dell as winner of 2013 C. Everett Koop National Health Award

Study identifies new tool to accurately analyze mtDNA deletions associated with diseases, aging

Study identifies new tool to accurately analyze mtDNA deletions associated with diseases, aging

Rochester Medical enters into definitive merger agreement with C. R. Bard

Rochester Medical enters into definitive merger agreement with C. R. Bard

First Edition: September 4, 2013

First Edition: September 4, 2013

Indicators of poor preoperative health predict risk of major medical complications

Indicators of poor preoperative health predict risk of major medical complications

CureDiva announces official launch of online breast cancer solutions store

CureDiva announces official launch of online breast cancer solutions store

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.